Protalix BioTherapeutics (PLX) Institutional Ownership $1.62 -0.03 (-1.82%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.66 +0.04 (+2.53%) As of 07:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)CurrentInstitutional OwnershipPercentage16.53%Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$5.97MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$672.90K Get PLX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PLX Institutional Buying and Selling by Quarter Protalix BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC294,318$753K0.0%+159.0%0.370% 5/16/2025 Goldman Sachs Group Inc.289,461$741K0.0%+482.3%0.364% 5/16/2025 NewEdge Advisors LLC15,080$39K0.0%N/A0.019% 5/15/2025 Cubist Systematic Strategies LLC53,380$137K0.0%+82.1%0.067% 5/15/2025 OMERS ADMINISTRATION Corp179,300$459K0.0%N/A0.225% 5/14/2025 Hsbc Holdings PLC25,535$64K0.0%-36.2%0.032% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.482,875$1.24M0.0%N/A0.607% 5/8/2025 XTX Topco Ltd41,826$107K0.0%N/A0.053% 5/8/2025 GSA Capital Partners LLP209,292$536K0.0%-31.5%0.263% 5/6/2025 Orin Green Financial LLC50,000$128K0.1%-30.6%0.063% Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/30/2025 Stratos Wealth Partners LTD.346,400$887K0.0%+28.3%0.444% 2/17/2025 Squarepoint Ops LLC73,940$139K0.0%+33.4%0.100% 2/17/2025 Point72 Asia Singapore Pte. Ltd.53,507$101K0.0%+13.7%0.073% 2/17/2025 Millennium Management LLC387,921$729K0.0%+3.8%0.527% 2/17/2025 Cubist Systematic Strategies LLC29,307$55K0.0%+24.1%0.040% 2/17/2025 Bank of America Corp DE33,714$63K0.0%-25.1%0.046% 2/14/2025 Jane Street Group LLC113,616$214K0.0%+147.2%0.154% 2/14/2025 Northern Trust Corp731,742$1.38M0.0%+1,299.4%0.994% 2/13/2025 Marshall Wace LLP101,899$192K0.0%N/A0.138% 2/13/2025 Renaissance Technologies LLC1,118,000$2.10M0.0%+17.0%1.518% 2/11/2025 Prudential Financial Inc.36,400$68K0.0%N/A0.049% 2/11/2025 Virtu Financial LLC34,276$64K0.0%-21.0%0.047% 2/4/2025 Y Intercept Hong Kong Ltd18,818$35K0.0%N/A0.026% 1/22/2025 PFG Investments LLC20,730$39K0.0%N/A0.028% 11/25/2024Sanctuary Advisors LLC37,100$38K0.0%N/A0.050% 11/20/2024 Virtu Financial LLC43,388$44K0.0%N/A0.059% 11/15/2024 XTX Topco Ltd35,058$36K0.0%N/A0.048% 11/15/2024 Jane Street Group LLC45,952$47K0.0%-84.2%0.062% 11/15/2024 Point72 Asia Singapore Pte. Ltd.47,073$48K0.0%-30.9%0.064% 11/5/2024 GSA Capital Partners LLP435,213$444K0.0%+8.5%0.592% 9/16/2024 Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 9/16/2024 Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% 8/15/2024 AQR Capital Management LLC57,106$67K0.0%N/A0.078% 8/15/2024 Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093% 8/14/2024 Squarepoint Ops LLC137,764$161K0.0%+673.3%0.188% 8/14/2024 Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044% 8/9/2024 Renaissance Technologies LLC804,600$941K0.0%-2.4%1.097% 8/8/2024 Ground Swell Capital LLC62,234$73K0.1%N/A0.085% 5/20/2024 Virtu Financial LLC157,516$198K0.0%N/A0.215% 5/7/2024 SG Americas Securities LLC21,467$27K0.0%-38.0%0.029% Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma5/3/2024 GSA Capital Partners LLP493,571$622K0.0%-9.3%0.673% 2/2/2024 Bailard Inc.68,100$121K0.0%N/A0.095% 1/19/2024 Denali Advisors LLC94,700$169K0.1%-14.1%0.132% 11/15/2023 GSA Capital Partners LLP496,781$825K0.1%N/A0.694% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234% 11/7/2023 Barclays PLC46,511$77K0.0%+251.6%0.065% 10/27/2023 Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193% 10/24/2023 Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231% 10/13/2023 SG Americas Securities LLC30,008$50K0.0%N/A0.042% 9/21/2023 Barclays PLC13,230$26K0.0%+561.5%0.018% 8/11/2023 Natixis132,000$264K0.0%N/A0.202% 8/4/2023 American International Group Inc.27,034$54K0.0%N/A0.041% 7/31/2023 Orin Green Financial LLC60,150$120K0.1%N/A0.092% 7/18/2023 Denali Advisors LLC110,200$220K0.1%N/A0.168% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243% 5/9/2023 Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024% 2/7/2023 Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101% 7/26/2022 Capital Performance Advisors LLP25,974$28K0.0%N/A0.055% 5/9/2022 Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527% 4/18/2022 Spire Wealth Management148,800$158K0.0%+18.3%0.321% 1/31/2022 Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088% 1/14/2022 Spire Wealth Management125,800$113K0.0%+598.9%0.276% 11/15/2021 GSA Capital Partners LLP254,871$339K0.0%N/A0.559% 11/12/2021Credit Suisse AG31,974$43K0.0%-51.5%0.070% 8/18/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 8/17/2021 Walleye Capital LLC346,539$662K0.0%N/A0.764% 8/17/2021 Walleye Trading LLC135,000$258K0.0%N/A0.297% 8/17/2021 Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868% 8/16/2021 Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102% 8/16/2021Credit Suisse AG65,925$126K0.0%+559.3%0.145% 8/13/2021 Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066% 8/12/2021 XTX Topco Ltd17,148$33K0.0%N/A0.038% 8/11/2021 Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146% 8/5/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 5/19/2021 Virtu Financial LLC27,744$124K0.0%N/A0.061% 5/18/2021Psagot Investment House Ltd.3,095,741$13.81M0.3%+558.3%6.821% 5/17/2021 Schonfeld Strategic Advisors LLC89,278$399K0.0%N/A0.197% 5/17/2021 DAFNA Capital Management LLC1,204,825$5.37M1.3%N/A2.655% 5/14/2021 Laurion Capital Management LP42,813$191K0.0%N/A0.094% 5/14/2021Credit Suisse AG10,000$45K0.0%N/A0.022% 5/13/2021 Renaissance Technologies LLC507,634$2.26M0.0%+3.9%1.119% 5/10/2021 Phoenix Holdings Ltd.244,113$1.09M0.0%N/A0.538% 5/7/2021 D.A. Davidson & CO.130,700$583K0.0%N/A0.288% (Data available from 1/1/2016 forward) PLX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PLX shares? During the previous two years, 33 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were Renaissance Technologies LLC ($2.10M), Northern Trust Corp ($1.38M), Connor Clark & Lunn Investment Management Ltd. ($1.24M), Stratos Wealth Partners LTD. ($887K), Jane Street Group LLC ($753K), Goldman Sachs Group Inc. ($741K), and Millennium Management LLC ($729K).Learn more on PLX's institutional investors. What percentage of Protalix BioTherapeutics stock is owned by institutional investors? 16.53% of Protalix BioTherapeutics stock is owned by institutional investors. Learn more on PLX's institutional investor holdings. Which institutional investors have been buying Protalix BioTherapeutics stock? Of the 31 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Northern Trust Corp ($679.45K), Connor Clark & Lunn Investment Management Ltd. ($534.87K), GSA Capital Partners LLP ($530.75K), Jane Street Group LLC ($248.37K), Goldman Sachs Group Inc. ($239.75K), Virtu Financial LLC ($200.90K), and OMERS ADMINISTRATION Corp ($179.30K). How much institutional buying is happening at Protalix BioTherapeutics? Institutional investors have bought a total of 4,296,030 shares in the last 24 months. This purchase volume represents approximately $6.29M in transactions. Which Protalix BioTherapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Jane Street Group LLC ($244.31K), GSA Capital Partners LLP ($147.12K), Orin Green Financial LLC ($22K), Point72 Asia Singapore Pte. Ltd. ($21.09K), Renaissance Technologies LLC ($20.10K), Denali Advisors LLC ($15.50K), and Hsbc Holdings PLC ($14.49K). How much institutional selling is happening at Protalix BioTherapeutics? Institutional investors have sold a total of 518,140 shares in the last 24 months. This volume of shares sold represents approximately $780.88K in transactions. Related Companies Mind Medicine (MindMed) Major Shareholders Valneva Major Shareholders Opthea Major Shareholders Eton Pharmaceuticals Major Shareholders Tyra Biosciences Major Shareholders Relay Therapeutics Major Shareholders REGENXBIO Major Shareholders Zevra Therapeutics Major Shareholders Upstream Bio Major Shareholders Amylyx Pharmaceuticals Major Shareholders This page (NYSE:PLX) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLX Stock Free PLX Stock Alerts